May 11, 2011
Glytec Earns U.S. Department of Commerce Safe Harbor Certification for European Union
Glytec, a world leader in glycemic management solutions, has announced that it has achieved the U.S. Department of Commerce Safe Harbor Certification.
Greenville, SC — The Safe Harbor provides a legal framework allowing for protection of personal data generated from European countries and the safe transfer of data to the U.S. By certifying to the Safe Harbor, Glytec had demonstrated compliance with the Safe Harbor privacy principles accepted by all 27 member stat Glytec Earns U.S. Department of Commerce Safe Harbor Certification for European Union.
Glytec, a world leader in glycemic management solutions, announced today that the company is among a select group of organizations that have achieved the U.S. Department of Commerce Safe Harbor Certification. The Safe Harbor provides a legal framework allowing for protection of personal data generated from European countries and the safe transfer of data to the U.S. By certifying to the Safe Harbor, Glytec had demonstrated compliance with the Safe Harbor privacy principles accepted by all 27 member states of the European Union.
An EU organization can ensure that it is sending information to a U.S. organization participating in Safe Harbor by viewing the public list posted on the Safe Harbor website: https://www.export.gov/safeharbor_eu
"We understand how important and sensitive patient health information can be," said Trefor Thomas, President and CEO of Glytec, "and we have taken this Certification step to demonstrate the strength of our commitment to preserve the highest standards of privacy for all patients whose healthcare providers use our Glucommander Plus™ software."
The Glytec system provides healthcare professionals with individualized insulin dosing requirements for hospitalized patients. The software includes many safety guardrails including predictive warnings and alerts, a fully-integrated and real-time reporting engine, and precision bolus dosing of meal-time insulin. The effects of poorly controlled blood glucose levels in hospitalized patients have long been known to cause serious complications such as an increased length of hospital stay, increased risk of infection, impaired wound healing, and increased risk of mortality.
About Glytec, LLC
Headquartered in Greenville, South Carolina, Glytec (www.glytecsystems.com) is leading the way with next generation glycemic control management systems for over 200 million diabetes patients worldwide. Glytec, LLC offers the only glycemic management system designed to stabilize excursions and maintain glucose levels within a predefined target range utilizing a unique series of safety guardrails that allow patients to achieve normoglycemia quickly and safely while minimizing the risk of cerebral edema, hypoglycemia, cardiac arrest, diabetes ketoacidosis (DKA) and neurological trauma.